COO Stock Falls -17% With A 9-day Losing Streak On Revenue Shock
Cooper Companies (COO) – a provider of medical devices, fertility, diagnostics, and lenses – hit a 9-day losing streak, with cumulative losses over this period amounting to -17%. The company’s market cap has crashed by about $2.7 Bil over the last 9 days and currently stands at $14 Bil.
The stock has YTD (year-to-date) return of 14.7% compared to -1% for S&P 500. This calls for a re-evaluation of the stock’s valuation to find out whether this is an opportunity or a trap.
What Triggered The Slide?
[1] Q1 2026 Earnings Report – Revenue Miss
- Q1 revenue of $1.02 billion missed analyst estimates of $1.04 billion
- 4% sales decline in the Asia-Pacific region due to weakness in Japan
- Impact: Sharp stock decline despite EPS beat, Trading volume more than doubled the average
Opportunity or Trap?
Below is our take on valuation.
There is a near-equal mix of good and bad in COO stock given its overall Moderate operating performance and financial condition. But keeping in mind its High valuation, we think that the stock is Unattractive (For details, see Buy or Sell COO).
But here is the real interesting point.
You are reading about this -17% move after it happened. The market has already priced in the news. To avoid the next loser before the headlines, you need predictive signals, not notifications. Our High Quality Portfolio has a risk model designed to reduce exposure to losers.
Returns vs S&P 500
The following table summarizes the return for COO stock vs. the S&P 500 index over different periods, including the current streak:
| Return Period | COO | S&P 500 |
|---|---|---|
| 1D | -2.2% | 0.0% |
| 9D (Current Streak) | -16.7% | -1.5% |
| 1M (21D) | -15.8% | -2.4% |
| 3M (63D) | -13.4% | -1.6% |
| YTD 2026 | -14.7% | -1.0% |
| 2025 | -10.8% | 16.4% |
| 2024 | -2.8% | 23.3% |
| 2023 | 14.5% | 24.2% |
Take a look at what history tells you about whether past dips like this have been buying opportunities or traps: COO Dip Buyer Analysis.
Gains and Losses Streaks: S&P 500 Constituents
There are currently 21.0 S&P constituents with 3 days or more of consecutive gains and 121 constituents with 3 days or more of consecutive losses.
| Consecutive Days | # of Gainers | # of Losers |
|---|---|---|
| 3D | 21 | 44 |
| 4D | 0 | 30 |
| 5D | 0 | 16 |
| 6D | 0 | 9 |
| 7D or more | 0 | 22 |
| Total >=3 D | 21 | 121 |
Key Financials for Cooper Companies (COO)
Last 2 Fiscal Years:
| Metric | FY2024 | FY2025 |
|---|---|---|
| Revenues | $3.9 Bil | $4.1 Bil |
| Operating Income | $705.7 Mil | $682.9 Mil |
| Net Income | $392.3 Mil | $374.9 Mil |
Last 2 Fiscal Quarters:
| Metric | 2025 FQ4 | 2026 FQ1 |
|---|---|---|
| Revenues | $1.1 Bil | $1.0 Bil |
| Operating Income | $140.4 Mil | $212.8 Mil |
| Net Income | $84.6 Mil | $130.8 Mil |
The losing streak COO stock is currently on doesn’t inspire much confidence among investors. In contrast, Trefis High Quality (HQ) Portfolio, with a collection of 30 stocks, has a track record of comfortably outperforming its benchmark that includes all 3 — the S&P 500, S&P mid-cap, and Russell 2000 indices. Why is that? As a group, HQ Portfolio stocks provided better returns with less risk versus the benchmark index; less of a roller-coaster ride, as evident in HQ Portfolio performance metrics.